Literature DB >> 30003385

Outcome of thyroid ultrasound screening in FAP patients with a normal baseline exam.

Marc Monachese1, Gautam Mankaney2, Rocio Lopez3, Margaret O'Malley4,5, Lisa Laguardia4,5, Matthew F Kalady4,5, James Church4,5, Joyce Shin5,6, Carol A Burke7,8,9.   

Abstract

Familial adenomatous polyposis (FAP) is a hereditary cancer syndrome associated with a substantial lifetime risk for colorectal cancer. The leading extra-colonic causes of cancer in FAP include duodenal and thyroid cancer (TC). Recent guidelines recommend annual thyroid ultrasound (TUS) screening beginning in the teenage years but the evidence to support the interval particularly in FAP patients with a normal baseline ultrasound is lacking. TUS results from FAP patients enrolled in a thyroid screening program from 2006 to 2016 and who had at least 2 TUS were reviewed. TUS findings were classified as normal, low (LR) or high risk (HR) for TC based on nodule characteristics as determined by American Thyroid Association (ATA) guidelines. We assessed the incidence of TC in patient with normal baseline TUS and factors associated with TC. 264 FAP patients were included. Baseline TUS was normal in 167, LR in 74, and HR in 24 patients. Patients were observed for a mean 4.8 years and underwent an average of 3 TUS. Patients with normal baseline TUS did not develop TC during the course of follow up of 5.1 years. TC developed in 6 patients (2.3%) all with baseline nodules; 5 in the LR group and 1 in the HR group. Factors associated with development of TC were presence of baseline nodule(s) and female sex. The development of TC in FAP patients in a TUS screening program with short term follow up is low and no FAP patient with a normal baseline TUS developed TC during observation. Annual TUS in patients with a normal baseline TUS may not be needed. Extending the screening interval to 2 years may be reasonable until nodules are detected.

Entities:  

Keywords:  Cancer screening; Familial adenomatous polyposis; Hereditary colorectal cancer; Thyroid cancer; Thyroid ultrasound

Mesh:

Year:  2019        PMID: 30003385     DOI: 10.1007/s10689-018-0097-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  24 in total

1.  Prevalence of thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations.

Authors:  Maite Herraiz; Giuseppe Barbesino; William Faquin; Gayun Chan-Smutko; Devanshi Patel; Kristen M Shannon; Gilbert H Daniels; Daniel C Chung
Journal:  Clin Gastroenterol Hepatol       Date:  2007-01-26       Impact factor: 11.382

2.  Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Dawn Provenzale; Samir Gupta; Dennis J Ahnen; Travis Bray; Jamie A Cannon; Gregory Cooper; Donald S David; Dayna S Early; Deborah Erwin; James M Ford; Francis M Giardiello; William Grady; Amy L Halverson; Stanley R Hamilton; Heather Hampel; Mohammad K Ismail; Jason B Klapman; David W Larson; Audrey J Lazenby; Patrick M Lynch; Robert J Mayer; Reid M Ness; Scott E Regenbogen; Niloy Jewel Samadder; Moshe Shike; Gideon Steinbach; David Weinberg; Mary Dwyer; Susan Darlow
Journal:  J Natl Compr Canc Netw       Date:  2016-08       Impact factor: 11.908

3.  Thyroid cancer in patients with familial adenomatous polyposis.

Authors:  N D Perrier; J A van Heerden; J R Goellner; E D Williams; H Gharib; P Marchesa; J M Church; V W Fazio; D R Larson
Journal:  World J Surg       Date:  1998-07       Impact factor: 3.352

4.  Association of thyroid carcinoma with Gardner's syndrome in siblings.

Authors:  M R Camiel; J E Mulé; L L Alexander; D L Benninghoff
Journal:  N Engl J Med       Date:  1968-05-09       Impact factor: 91.245

5.  Thyroid nodule size and prediction of cancer.

Authors:  Sophia C Kamran; Ellen Marqusee; Mathew I Kim; Mary C Frates; Julie Ritner; Hope Peters; Carol B Benson; Peter M Doubilet; Edmund S Cibas; Justine Barletta; Nancy Cho; Atul Gawande; Daniel Ruan; Francis D Moore; Karla Pou; P Reed Larsen; Erik K Alexander
Journal:  J Clin Endocrinol Metab       Date:  2012-12-28       Impact factor: 5.958

6.  Extracolonic cancer risk in Dutch patients with APC (adenomatous polyposis coli)-associated polyposis.

Authors:  Zeinab Ghorbanoghli; Barbara Aj Bastiaansen; Alexandra Mj Langers; Fokko M Nagengast; Jan-Werner Poley; James Ch Hardwick; Jan J Koornstra; Silvia Sanduleanu; Wouter H de Vos Tot Nederveen Cappel; Ben Jm Witteman; H Morreau; Evelien Dekker; Hans Fa Vasen
Journal:  J Med Genet       Date:  2017-05-10       Impact factor: 6.318

7.  Gene variants associated to malignant thyroid disease in familial adenomatous polyposis: a novel APC germline mutation.

Authors:  A Martayan; L Sanchez-Mete; R Baldelli; E Falvo; A Barnabei; L Conti; P Giacomini; M Appetecchia; V Stigliano
Journal:  J Endocrinol Invest       Date:  2010-10-08       Impact factor: 4.256

8.  Age- and Gender-Specific Risk of Thyroid Cancer in Patients With Familial Adenomatous Polyposis.

Authors:  Shinya Uchino; Hideki Ishikawa; Akira Miyauchi; Mitsuyoshi Hirokawa; Shiro Noguchi; Mineko Ushiama; Teruhiko Yoshida; Masahito Michikura; Kokichi Sugano; Toshiyuki Sakai
Journal:  J Clin Endocrinol Metab       Date:  2016-09-13       Impact factor: 5.958

9.  Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma.

Authors:  Brindusa Truta; Brian A Allen; Peggy G Conrad; Young S Kim; Terri Berk; Steven Gallinger; Bharati Bapat; Jonathan P Terdiman; Marvin H Sleisenger
Journal:  Fam Cancer       Date:  2003       Impact factor: 2.375

10.  Genetic alterations in thyroid carcinoma associated with familial adenomatous polyposis: clinical implications and suggestions for early detection.

Authors:  F Cetta; S Olschwang; M Petracci; G Montalto; C Baldi; M Zuckermann; R Mariani Costantini; A Fusco
Journal:  World J Surg       Date:  1998-12       Impact factor: 3.352

View more
  2 in total

1.  Bibliometric analysis of research on thyroid ultrasonography.

Authors:  Juan Su; Guanghui Gao; Hongxia Xu
Journal:  Gland Surg       Date:  2021-12

Review 2.  Chemoprevention in familial adenomatous polyposis: past, present and future.

Authors:  Phillip M Kemp Bohan; Gautam Mankaney; Timothy J Vreeland; Robert C Chick; Diane F Hale; Jessica L Cindass; Annelies T Hickerson; Daniel C Ensley; Vance Sohn; G Travis Clifton; George E Peoples; Carol A Burke
Journal:  Fam Cancer       Date:  2020-06-08       Impact factor: 2.375

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.